Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial

BACKGROUND: Cigarette smoking has emerged as a leading cause of mortality among people with hepatitis C virus (HCV). People who inject drugs (PWID) represent the largest group of adults infected with HCV in the US. However, cigarette smoking remains virtually unexplored among this population. This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Pericot-Valverde, Irene, Heo, Moonseong, Akiyama, Matthew J., Norton, Brianna L., Agyemang, Linda, Niu, Jiajing, Litwin, Alain H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718688/
https://www.ncbi.nlm.nih.gov/pubmed/33276738
http://dx.doi.org/10.1186/s12879-020-05667-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718688/
https://www.ncbi.nlm.nih.gov/pubmed/33276738
http://dx.doi.org/10.1186/s12879-020-05667-3

Ejemplares similares